NIH Center Would Seek To Boost “Repurposing” Of Shelved Drug Candidates

A proposed new center at the National Institutes of Health dedicated to speeding “translation” of biomedical research into therapies may focus initially on exploring new uses for drug candidates shelved by pharmaceutical firms, according to NIH Director Francis Collins.